Health care companies dominate the MAHA Summit, and a look at Trump's watered down effort to lower Medicare drug prices. Medicare CMS research Newsletters Log In My Account Subscribe Now My Account Settings Complete your personal information for a more tailored experience Saved Stories Billing Log Out Reporting from the frontiers of health and medicine Newsletters Log In My Account Subscribe Now Biotech Pharma Public Health Health Tech Policy Science First Opinion STAT+ STAT Events Search Log In Try STAT+ My Account My Account Settings Saved Stories Billing History Home Newsletter D.C. Diagnosis MAHA goes corporate You’re reading STAT’s D.C.…
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.
Michigan Democratic Senate candidate Abdul El-Sayed announced his Building a Healthier America policy agenda to co-opt the MAHA movement. So it’s BAHA vs. MAHA now. Send news tips and tortured acronyms to John.Wilkerson@statnews.com or John_Wilkerson.07 on Signal.
MAHA Corp.
MAHA dove headlong into the swamp this week.
Continue to STAT+ to read the full story…
US Pharma Marketing